← Back to headlines
Argenx SE to Showcase Vyvgart's Efficacy in Broader Autoimmune Diseases
Argenx SE is preparing to present evidence of its drug Vyvgart's effectiveness across a wider spectrum of autoimmune diseases, potentially expanding its therapeutic applications.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
